Evidence map›Paper›PMID 39885114›Full record

ArticleGeroScience2025

Role for neurological and immunological resilience in the pathway of the aging muscle powerpenia: InCHIANTI study longitudinal results.

Raffaello Pellegrino, Roberto Paganelli, Angelo Di Iorio, Matteo Candeloro, Stefano Volpato, Stefania Bandinelli, Antimo Moretti, Giovanni Iolascon, Toshiko Tanaka, Luigi Ferrucci

Abstract read
In one paragraph

Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raffaello PellegrinoDepartment of Scientific Research, Campus Ludes, Off-Campus Semmelweis University, 6912, Lugano-Pazzallo, Switzerland.ORCID 0000-0001-5874-0376
Roberto PaganelliSaint Camillus International University of Health and Medical Sciences, Rome, Italy.ORCID 0000-0003-3467-9317
Angelo Di IorioDepartment of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" Chieti-Pescara, Viale Abruzzo 322, 66100, Chieti-Pescara, Italy. a.diiorio@unich.it.ORCID 0000-0003-2899-146X
Matteo CandeloroDepartment of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" Chieti-Pescara, Viale Abruzzo 322, 66100, Chieti-Pescara, Italy.ORCID 0000-0001-9673-4073
Stefano VolpatoDepartment of Medical Sciences, University of Ferrara, 44121, Ferrara, Italy.ORCID 0000-0003-4335-6034
Stefania BandinelliAzienda USL Toscana Centro, InCHIANTI, Villa Margherita, Primo Piano Viale Michelangelo, 41, 50125, Florence, Italy.ORCID 0000-0002-6491-0850
Antimo MorettiDepartment of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy.ORCID 0000-0002-4598-2891
Giovanni IolasconDepartment of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy.ORCID 0000-0002-0976-925X
Toshiko TanakaLongitudinal Studies Section, Translational Gerontology Branch, National Institute On Aging, National Institutes of Health, Baltimore, MD, 21224, USA.ORCID 0000-0002-4161-3829
Luigi FerrucciLongitudinal Studies Section, Translational Gerontology Branch, National Institute On Aging, National Institutes of Health, Baltimore, MD, 21224, USA.ORCID 0000-0002-6273-1613

Funding

Oxidative stress and the pathogenesis of sarcopenia and disability in older womenR01AG027012 · NIA · JOHNS HOPKINS UNIVERSITY · PI SEMBA, RICHARD D · 2005 to 2018
$3.6M
Ministero della Salute ICS 110.1/RS97.71NIA NIH HHS N01-AG-5-0002NIA NIH HHS N01-AG-821336NIA NIH HHS N01-AG-916413NIA NIH HHS R01 AG027012NIA NIH HHS R01-AG-027012
6 · The paper itself

Abstract

The neuromuscular junction shows several degenerative changes with aging, resulting in a reduction of transmission efficacy. These changes, paired with low-grade chronic inflammation, were considered triggers of the aging muscle processes. The main objective of this study is to assess the role of leukocyte count-derived ratios, nerve conduction velocity (NCV), and compound muscle action potential (CMAP) in determining time-dependent reduction in lower limb muscle explosive strength, a condition that has been defined as powerpenia. The InCHIANTI study enrolled a representative sample from the registry lists of two towns in Tuscany, Italy. Baseline data were collected in 1998, with follow-up visits every 3 years. For the purpose of this analysis, we used 1229 subjects and 3814 follow-up assessments. Subjects with lower values of monocyte-to-lymphocyte ratio (ML-ratio) had higher nerve conduction velocity and higher proximal and distal action potential values; moreover, considering the interaction between age for ML-ratio effect, a statistically significant direct association is found with all the electromyography-parameters. Lower limb muscle power shows a gender dimorphism, male subjects having higher values at baseline, but experiencing steeper decline rate during the follow-up, compared to females. Muscle power was inversely associated with ML-ratio, proximal CMAP, distal CMAP, and NCV. Moreover, we found a direct and statistically significant second-order interaction (age for ML-ratio), meaning that at the same age, increasing ML-ratio increases lower limb muscle power. Lastly, also body composition variation across aging is directly associated with lower limb muscle power. Reduced immunological and neurological homeostasis affects the powerpenia phenotype in a large representative sample of Italian men and women.

Indexed as

AgingMuscle, SkeletalMuscle StrengthAction PotentialsAgedAged, 80 and overElectromyographyFemaleHumansItalyLeukocyte CountLongitudinal StudiesLower ExtremityMaleMiddle AgedNeural ConductionInflammagingMuscleNervous systemPowerpeniaSarcopenia

Identifiers

PMID39885114
PMCPMC12397046

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.